Investigation of Balkan endemic nephropathy in Serbia: How to proceed?

Balkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and...

Full description

Bibliographic Details
Main Authors: Đukanović Ljubica, Stefanović Vladisav, Basta-Jovanović Gordana, Bukvić Danica, Glogovac Stevan, Dimitrijević Jovan, Đurić Sunčica, Janković Slavenka, Lukić Ljiljana, Marić Ivko, Nikolić Jovan, Novaković Ivana, Pejović Vesna, Radisavljević Snežana, Rakić
Format: Article
Language:English
Published: Serbian Medical Society 2010-01-01
Series:Srpski Arhiv za Celokupno Lekarstvo
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdf
id doaj-7388c7cdba6f490d95194050af129a42
record_format Article
spelling doaj-7388c7cdba6f490d95194050af129a422021-01-02T05:37:01ZengSerbian Medical SocietySrpski Arhiv za Celokupno Lekarstvo0370-81792010-01-011383-425626110.2298/SARH1004256DInvestigation of Balkan endemic nephropathy in Serbia: How to proceed?Đukanović LjubicaStefanović VladisavBasta-Jovanović GordanaBukvić DanicaGlogovac StevanDimitrijević JovanĐurić SunčicaJanković SlavenkaLukić LjiljanaMarić IvkoNikolić JovanNovaković IvanaPejović VesnaRadisavljević SnežanaRakićBalkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and conclusions of this meeting. During the last fifty years, the course of BEN prolonged and it shifted towards the older age in all endemic foci. Data on the incidence of BEN have been controversial and frequently based on the data on the number of BEN patients starting haemodialysis treatment. In Serbia, BEN patients present 6.5% of haemodialysis population and this percentage differs among different centres ranging from 5% (Leskovac) to 46% (Lazarevac). Maintenance of high prevalence of BEN patients on regular haemodialysis indicates that BEN is not an expiring disease. In addition, recent data have shown more frequent microalbuminuria and low-molecular weight proteinuria in children from endemic than from nonendemic families. Aetiology of BEN is still unknown despite numerous investigations of environmental and genetic factors. Today, there is a very current hypothesis on the aetiological role of aristolochic acid but the role of viruses, geochemical factors and genetic factors must not be neglected. Morphological features of BEN are nonspecific and characterized by acellular interstitial fibrosis, tubular atrophy and changes on preand postglomerular vessels. New immunohistochemical and molecular biology methods offer a new approach to BEN investigation. Association of BEN with high incidence of upperurothelial tumours is well-known. Recent studies have shown significant changes of demographic characteristics of patients suffering upper-urothelial tumours, their prevalence in different endemic foci and characteristics of tumours. Further studies of BEN should be directed to determination of incidence and prevalence of disease in different endemic foci, investigations of different insufficiently examined aetiological factors as well as pathomorphological features of the disease by the use of modern methods. http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdfBalkan endemic nephropathyepidemiologyAetiology
collection DOAJ
language English
format Article
sources DOAJ
author Đukanović Ljubica
Stefanović Vladisav
Basta-Jovanović Gordana
Bukvić Danica
Glogovac Stevan
Dimitrijević Jovan
Đurić Sunčica
Janković Slavenka
Lukić Ljiljana
Marić Ivko
Nikolić Jovan
Novaković Ivana
Pejović Vesna
Radisavljević Snežana
Rakić
spellingShingle Đukanović Ljubica
Stefanović Vladisav
Basta-Jovanović Gordana
Bukvić Danica
Glogovac Stevan
Dimitrijević Jovan
Đurić Sunčica
Janković Slavenka
Lukić Ljiljana
Marić Ivko
Nikolić Jovan
Novaković Ivana
Pejović Vesna
Radisavljević Snežana
Rakić
Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
Srpski Arhiv za Celokupno Lekarstvo
Balkan endemic nephropathy
epidemiology
Aetiology
author_facet Đukanović Ljubica
Stefanović Vladisav
Basta-Jovanović Gordana
Bukvić Danica
Glogovac Stevan
Dimitrijević Jovan
Đurić Sunčica
Janković Slavenka
Lukić Ljiljana
Marić Ivko
Nikolić Jovan
Novaković Ivana
Pejović Vesna
Radisavljević Snežana
Rakić
author_sort Đukanović Ljubica
title Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
title_short Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
title_full Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
title_fullStr Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
title_full_unstemmed Investigation of Balkan endemic nephropathy in Serbia: How to proceed?
title_sort investigation of balkan endemic nephropathy in serbia: how to proceed?
publisher Serbian Medical Society
series Srpski Arhiv za Celokupno Lekarstvo
issn 0370-8179
publishDate 2010-01-01
description Balkan endemic nephropathy (BEN) presents an unsolved puzzle despite fifty years of its investigation. Academy of Medical Sciences of the Serbian Medical Society organized a round table discussion on current unsolved problems related to BEN. The present paper summarizes presentations, discussion and conclusions of this meeting. During the last fifty years, the course of BEN prolonged and it shifted towards the older age in all endemic foci. Data on the incidence of BEN have been controversial and frequently based on the data on the number of BEN patients starting haemodialysis treatment. In Serbia, BEN patients present 6.5% of haemodialysis population and this percentage differs among different centres ranging from 5% (Leskovac) to 46% (Lazarevac). Maintenance of high prevalence of BEN patients on regular haemodialysis indicates that BEN is not an expiring disease. In addition, recent data have shown more frequent microalbuminuria and low-molecular weight proteinuria in children from endemic than from nonendemic families. Aetiology of BEN is still unknown despite numerous investigations of environmental and genetic factors. Today, there is a very current hypothesis on the aetiological role of aristolochic acid but the role of viruses, geochemical factors and genetic factors must not be neglected. Morphological features of BEN are nonspecific and characterized by acellular interstitial fibrosis, tubular atrophy and changes on preand postglomerular vessels. New immunohistochemical and molecular biology methods offer a new approach to BEN investigation. Association of BEN with high incidence of upperurothelial tumours is well-known. Recent studies have shown significant changes of demographic characteristics of patients suffering upper-urothelial tumours, their prevalence in different endemic foci and characteristics of tumours. Further studies of BEN should be directed to determination of incidence and prevalence of disease in different endemic foci, investigations of different insufficiently examined aetiological factors as well as pathomorphological features of the disease by the use of modern methods.
topic Balkan endemic nephropathy
epidemiology
Aetiology
url http://www.doiserbia.nb.rs/img/doi/0370-8179/2010/0370-81791004256D.pdf
work_keys_str_mv AT đukanovicljubica investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT stefanovicvladisav investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT bastajovanovicgordana investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT bukvicdanica investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT glogovacstevan investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT dimitrijevicjovan investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT đuricsuncica investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT jankovicslavenka investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT lukicljiljana investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT maricivko investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT nikolicjovan investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT novakovicivana investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT pejovicvesna investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT radisavljevicsnezana investigationofbalkanendemicnephropathyinserbiahowtoproceed
AT rakic investigationofbalkanendemicnephropathyinserbiahowtoproceed
_version_ 1724358766779957248